Drug profile · INN
ertapenem sodium
ERTAPENEM SODIUM
ertapenem sodium (ERTAPENEM SODIUM) is a bacterial penicillin-binding protein inhibitor. Route of administration: intramuscular, intravenous. Current US regulatory status: approved.
Drug details — ertapenem sodium
- US status
- approved
- Class
- —
- Route
- INTRAMUSCULAR, INTRAVENOUS
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
ertapenem sodium (ERTAPENEM SODIUM) is a bacterial penicillin-binding protein inhibitor. Route of administration: intramuscular, intravenous. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial penicillin-binding protein inhibitor
Primary target: Bacterial penicillin-binding protein
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is ertapenem sodium?
ertapenem sodium (ERTAPENEM SODIUM) is a bacterial penicillin-binding protein inhibitor. Route of administration: intramuscular, intravenous. Current US regulatory status: approved.
What is the brand name for ertapenem sodium?
ERTAPENEM SODIUM is a marketed brand name for ertapenem sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ertapenem sodium?
ertapenem sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.